News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement

Thomas Bertels

Advertisement

Articles by Thomas Bertels

Market Access Reinvented

ByThomas Bertels,Peter Vanovertveld
November 11th 2015

Pharmaceutical Executive

The key steps to implementing the "patient access" model of the future

Advertisement

Latest Updated Articles

  • Market Access Reinvented
    Market Access Reinvented

    November 11th 2015



Advertisement
Advertisement

Trending on PharmExec

1

Eli Lilly Enters $7 Billion Agreement to Acquire Kelonia Therapeutics

2

President Trump Signs Executive Order to Accelerate FDA Reviews for Psychedelic Drugs

3

Pfizer at a Crossroads: Leadership, Strategy, and the Risk of a Narrative Cliff

4

Addressing Regulatory Issues and the Biosimilar Void: Q&A with Thomas Newcomer

5

Inside Pharma's Revenue Engine: The Gross-to-Net Reckoning

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us